about
HilleVax Inc is a clinical-stage biopharmaceutical company. The company is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of mod...
Read More
2.09
-0.01
(-0.48%)
104.8K
XNAS Volume
XNAS 11 Jul, 2025 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
HilleVax Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..